$FRX Recent News U.S. stock market is starting t
Post# of 88926
Posted On: 02/24/2014 11:29:16 AM
$FRX Recent News
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Today - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 2:04 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
As Forest Labs soars, Carl Icahn says activists are force for good 11:01 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
Forest Laboratories surge 30% in early trade 9:33 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Newscast: Wall Street aiming for gains 7:35 a.m. Feb. 18, 2014 - MarketWatch
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Today - Seeking Alpha
CHMP Positive on Glaxo's Two Drugs - Analyst Blog 4:45 p.m. Feb. 21, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 12:03 p.m. Feb. 21, 2014 - TheStreet.com
Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 9:46 a.m. Feb. 21, 2014 - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Feb. 21, 2014 - InvestorPlace.com
Data on Novartis Skin Cancer Treatment - Analyst Blog 4:50 p.m. Feb. 20, 2014 - Zacks.com
Eli Lilly Up on Positive Ramucirumab Data - Analyst Blog 4:10 p.m. Feb. 20, 2014 - Zacks.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Two Turnarounds Still on the Move 10:30 a.m. Feb. 20, 2014 - RealMoney.com
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
Can Shire (SHPG) Continue to Surge? - Tale of the Tape 8:38 a.m. Feb. 20, 2014 - Zacks.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
SA PRO: Top Long And Short Ideas, Wednesday February 19 7:30 a.m. Feb. 20, 2014 - Seeking Alpha
FDA Approves Shire's New Facility - Analyst Blog 6:36 p.m. Feb. 19, 2014 - Zacks.com
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
Winning Stock Sectors for Tuesday, February 18 12:30 p.m. Feb. 19, 2014 - WallStreetSectorSelector
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com
Forest Laboratories, Inc. Launches STRIDE Patient Support Program for COPD Franchise Products Tudorza® Pressair® and Daliresp® 8:00 a.m. Today - BusinessWire - BZX
Law Firm Brower Piven Announces Investigation of Forest Laboratories, Inc. Proposed Buyout 11:22 a.m. Feb. 21, 2014 - BusinessWire - BZX
FOREST LABORATORIES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 5:32 p.m. Feb. 19, 2014 - BusinessWire - BZX
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Forest Laboratories, Inc. 11:40 a.m. Feb. 19, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover 9:54 a.m. Feb. 19, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Forest Laboratories, Inc. - FRX 4:04 p.m. Feb. 18, 2014 - PR Newswire - PRF
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
Forest Laboratories Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Actavis 11:47 a.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST LABORATORIES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 9:58 a.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Forest Laboratories to Discontinue NAMENDA® Tablets, Focus on Once-Daily NAMENDA XR® 4:15 p.m. Feb. 14, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Completes $2.9B Acquisition of Aptalis 8:30 a.m. Feb. 3, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR® Patents 4:05 p.m. Jan. 31, 2014 - BusinessWire - BZX
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Today - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 2:04 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
As Forest Labs soars, Carl Icahn says activists are force for good 11:01 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
Forest Laboratories surge 30% in early trade 9:33 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Newscast: Wall Street aiming for gains 7:35 a.m. Feb. 18, 2014 - MarketWatch
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Today - Seeking Alpha
CHMP Positive on Glaxo's Two Drugs - Analyst Blog 4:45 p.m. Feb. 21, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 12:03 p.m. Feb. 21, 2014 - TheStreet.com
Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 9:46 a.m. Feb. 21, 2014 - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Feb. 21, 2014 - InvestorPlace.com
Data on Novartis Skin Cancer Treatment - Analyst Blog 4:50 p.m. Feb. 20, 2014 - Zacks.com
Eli Lilly Up on Positive Ramucirumab Data - Analyst Blog 4:10 p.m. Feb. 20, 2014 - Zacks.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Two Turnarounds Still on the Move 10:30 a.m. Feb. 20, 2014 - RealMoney.com
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
Can Shire (SHPG) Continue to Surge? - Tale of the Tape 8:38 a.m. Feb. 20, 2014 - Zacks.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
SA PRO: Top Long And Short Ideas, Wednesday February 19 7:30 a.m. Feb. 20, 2014 - Seeking Alpha
FDA Approves Shire's New Facility - Analyst Blog 6:36 p.m. Feb. 19, 2014 - Zacks.com
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
Winning Stock Sectors for Tuesday, February 18 12:30 p.m. Feb. 19, 2014 - WallStreetSectorSelector
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com
Forest Laboratories, Inc. Launches STRIDE Patient Support Program for COPD Franchise Products Tudorza® Pressair® and Daliresp® 8:00 a.m. Today - BusinessWire - BZX
Law Firm Brower Piven Announces Investigation of Forest Laboratories, Inc. Proposed Buyout 11:22 a.m. Feb. 21, 2014 - BusinessWire - BZX
FOREST LABORATORIES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 5:32 p.m. Feb. 19, 2014 - BusinessWire - BZX
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Forest Laboratories, Inc. 11:40 a.m. Feb. 19, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover 9:54 a.m. Feb. 19, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Forest Laboratories, Inc. - FRX 4:04 p.m. Feb. 18, 2014 - PR Newswire - PRF
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
Forest Laboratories Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Actavis 11:47 a.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST LABORATORIES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 9:58 a.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Forest Laboratories to Discontinue NAMENDA® Tablets, Focus on Once-Daily NAMENDA XR® 4:15 p.m. Feb. 14, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Completes $2.9B Acquisition of Aptalis 8:30 a.m. Feb. 3, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR® Patents 4:05 p.m. Jan. 31, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼